Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
MarTech for Pharma in India: Indian Pharma’s 2025 Marketing Tech Stack
The Indian pharmaceutical industry isn’t playing catch-up anymore. It’s leading, especially when it comes to how it connects with doctors and patients. What’s driving that change? A sharper, smarter…
|
How CMOs Can Use Marketing Automation to Improve Doctor Engagement in Tier 2 and 3 India
For CMOs and Digital Brand Managers in the Indian pharmaceutical industry, the conversation has shifted. It’s no longer about reach; it’s about resonance. Especially in Tier 2 and 3 cities, where the…
|
A CMO's Guide: Why Traditional Pharma Digital Marketing in India Is Dying (And What to Do About It)
The era of field-rep-only marketing is over. Now, even the most established pharmaceutical giants are struggling to keep up with the pace of change. What once worked (rep visits, CME events, reminder…
|
What Is the Uniform Code for Pharmaceutical Marketing Practices UCPMP 2024?
The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 marks a pivotal shift in how pharma companies engage in promotions and communications. Issued by India’s Department of…
